Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study
Clara Grazia Chisari(University of Catania), Francesco Patti(University of Catania), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Simona Pontecorvo(Sapienza University of Rome), Pasquale Annunziata, Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Daniele Spitaleri(Azienda Ospedaliera S.Giuseppe Moscati), Paola Valentino(Magna Graecia University), Letizia Castelli(Multiple Sclerosis Foundation), Claudio Gasperini(Nini Hospital), Loredana Petrucci(University of Pisa), Isabella Righini, Mario Zappia(University of Catania), Alberto Gajofatto(University of Verona), Roberta Lanzillo(University of Naples Federico II), Gianfranco Costantino(Ospedali Riuniti di Foggia), Elisabetta Capello(Ospedale Policlinico San Martino), Roberto Bruno Bossio(Azienda Ospedaliera di Cosenza), Marco Rovaris(San Raffaele University of Rome), Simona Bonavita, Damiano Paolicelli(University of Bari Aldo Moro), Paola Cavalla, Edoardo Sessa(Centro Neurolesi Bonino Pulejo), Manuela Matta(Ospedale San Luigi Gonzaga), Gabriella Spinicci(University of Cagliari), Assunta Bianco(Università Cattolica del Sacro Cuore), Giacomo Lus(University of Campania "Luigi Vanvitelli"), Claudio Solaro(Rina Services (Italy)), Vincenzo Brescia Morra(Federico II University Hospital), Giorgia Teresa Maniscalco(Ospedale Antonio Cardarelli), Salvatore Cottone, Angelica Guareschi(University of Campania "Luigi Vanvitelli"), Diego Centonze(University of Rome Tor Vergata), Maura Danni(Multiple Sclerosis Foundation), Federica Esposito(Vita-Salute San Raffaele University)
Cited by 9
Related Papers
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646